DNLI
Denali Therapeutics Inc
20.50$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6,895.3% | – | – | – | – | – | – | – | – | – | – | -2,691.5% | -12,043.3% | |
| 175.0% | – | – | – | – | – | – | – | – | – | – | 73.6% | 364.7% | |
| 2,167.3% | – | – | – | – | – | – | – | – | – | – | 635.8% | 2,638.4% | |
| -347.8% | – | – | – | – | – | – | – | – | – | – | 120.6% | -675.8% | |
| 163.2% | – | – | – | – | – | – | – | – | – | – | 22.3% | 171.3% | |
| 7,964.4% | – | – | – | – | – | – | – | – | – | – | -2,887.8% | 1,914.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -0.6% | -39.3% | |
| 196.7% | – | – | – | – | – | – | – | – | – | – | 415.8% | 11,803.1% | |
| 1,265.8% | – | – | – | – | – | – | – | – | – | – | -5,163.6% | 1,673.8% | |
| -7,058.5% | – | – | – | – | – | – | – | – | – | – | -2,713.8% | -12,138.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.